Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)
Clinical trial NCT03620747 · COMPLETED
Trial details
- NCT number
- NCT03620747
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-30
- Primary completion
- 2022-02-18
- Enrollment
- 393
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.